Cidara Therapeutics to Report Third Quarter 2017 Financial Results and Provide Corporate Update
01 nov. 2017 16h05 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will...
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
19 oct. 2017 09h00 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
Cidara Provides Corporate Update and Reports First Quarter 2017 Financial Results
10 mai 2017 17h06 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Therapeutics to Host Investor Day on April 6, 2017
29 mars 2017 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 29, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, will host an Investor Day...
Cidara Provides Corporate Update and Reports Third Quarter 2016 Financial Results
10 nov. 2016 16h10 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Therapeutics to Present at the Stifel 2016 Healthcare Conference
08 nov. 2016 16h05 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced it will...
Cidara Therapeutics and Square 1 Bank Announce $20 Million Credit Facility
02 nov. 2016 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics Announces Closing of Public Offering of Common Stock, Including Exercise of Underwriter’s Option to Purchase Additional Shares
13 oct. 2016 09h20 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the closing...